Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Clinical Genitourinary Cancer|August 17, 2024
Immune-Related Adverse Events Can Predict Progression-Free and Overall Survival In Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint InhibitorsMatteo Silberg, Laura-Maria Krabbe, Martin Bögemann, et al.Urologia Internationalis|December 16, 2024
Discrimination of T-Stage Using Tumor Weight and Size: A Potential Approach to Guide Perioperative Decision-Making in Patients with Bladder CancerKarl Tully, Henning Bahlburg, Moritz J Reike, et al.Journal of Cancer Survivorship : Research and Practice|May 5, 2023
Return to work improves quality of life and reduces psychosocial distress after radical cystectomy: data from a contemporary series of 230 German patientsHenning Bahlburg, Moritz Reike, Karl Tully, et al.Journal of Cancer Survivorship : Research and Practice|May 10, 2023
Psychosocial distress and quality of life in patients after radical cystectomy - one year follow-up in 842 German patientsHenning Bahlburg, Tabea Hellmann, Karl Tully, et al.Clinical Genitourinary Cancer|June 12, 2022
Complications in the Early Recovery Period After Radical Cystectomy-Real Data From Impartial Inpatient RehabilitationMayumi Götte, Henning Bahlburg, Marius Cristian Butea-Bocu, et al.Surgical Oncology|September 17, 2025
The utility of preoperative diagnostics in patients undergoing radical nephroureterectomy for suspected upper tract urothelial carcinoma: Can we justify treatment without prior histologic confirmation?Vincent Hoffmann, Martina Dellino, Henning Bahlburg, et al.Translational Andrology and Urology|April 13, 2019
Transurethral resection of bladder tumours: established and new methods of tumour visualisationKarl Tully, Rein-Jüri Palisaar, Marko Brock, et al.Urologia Internationalis|April 16, 2023
Avoiding Prostate Biopsies in Patients at Low Risk for Prostate Cancer: A Prospective Evaluation of a PSA-Density-Based Safety NetHenning Bahlburg, Karl Tully, Vincent Hoffmann, et al.Journal of Personalized Medicine|June 2, 2021
KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder CancerHendrik Jütte, Moritz Reike, Ralph M Wirtz, et al.European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinomaNiklas Klümper, Danijel Sikic, Jonas Saal, et al.Pageof 3